Leslie knows a lot of terrible things happened during COVID, so she thought you might like to hear an uplifting story.
Our experts discuss the factors contributing to excess deaths worldwide, particularly those associated with COVID-19 infections and vaccines.
In opening remarks at the FLCCC Alliance Winter Conference 2024, Dr. Chris Martenson speaks about moving from "sick care" to wellness.
A retired R.N. and a medically retired Nurse Corp Officer, she never saw herself as “anti-vax”. While in the military, she took all the mandated vaccines, even when her record said she was allergic to vaccines.
The lingering effects of COVID-19 and vaccine-related health issues present ongoing challenges for many patients, sadly, including children as well. Here, Dr. Flavio Cadegiani discusses current mandates for children in Brazil.
During COVID Becky found the FLCCC's website and all the protocols she could share. For her, ivermectin is a miracle.
Dr. Yusuf (JP) Saleeby shares the case of a patient suffering from post-vaccine injury, and explores the differences between long COVID and long vax at a panel discussion at the FLCCC Alliance Educational Conference in Phoenix, February 2024.
This 77-year-old believes everyone should, "be concerned about another COVID-like onslaught.” His best advice: get in the best shape we can, and have our own health bundles on the ready. Do you have an early treatment kit?
At the 3rd FLCCC Alliance educational conference in Phoenix, Clare, a PA-C, wanted you to know that if you're a patient who's dealing with itching or burning skin, and there are no skin findings, it might be a type of neuropathy that could be creating these symptoms.
As Dr. Pierre Kory embarks on a significant transition, we take a moment to honor his remarkable journey and enduring impact on the FLCCC Alliance and beyond. Dr. Kory is not just stepping down as a leader; he is stepping into a new role as FLCCC co-founder and President Emeritus, all while directing his energies towards his growing practice and advocacy efforts.